Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)

Clinical trial NCT00206219 · COMPLETED

Trial details

NCT number: NCT00206219
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Head and Neck

Start date: 2003-11-01
Primary completion: 2007-09-01
Enrollment: 477

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.